Pediatric Cancer

2 protocols meet the specified criteria.

  • COG-ANBL2131

    A Phase 3 Study of Dinutuximab Added to Intensive Multimodal Therapy for Children with Newly Diagnosed High-Risk Neuroblastoma

  • COG-APEC14B1

    APEC14B1 - Project: EveryChild - A Registry, Eligibility Screening, Biology and Outcome Study.